LncRNA MALAT1 functions as a competing endogenous RNA to regulate ZEB2 expression by sponging miR-200s in clear cell kidney carcinoma
暂无分享,去创建一个
Ke Chen | Heng Li | Kun Tang | Yingtian Pan | Haibing Xiao | Zhangqun Ye | Hua Xu | Qihong Huang | Anping Li | Ke Chen | Z. Ye | Hua Xu | Peijun Liu | Yingtian Pan | K. Tang | Gan Yu | Weimin Yao | Ji Wang | Wei-huan Xiao | Hai-bing Xiao | Heng Li | Qihong Huang | Anping Li | Hui Zhou | Jin Zeng | Junhui Hu | Peijun Liu | Junhui Hu | Jin Zeng | Wei Xiao | Gan Yu | Weiming Yao | Hui Zhou | Ji Wang
[1] Pieter C. Dorrestein,et al. ncRNA- and Pc2 Methylation-Dependent Gene Relocation between Nuclear Structures Mediates Gene Activation Programs , 2011, Cell.
[2] Hui Zhou,et al. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein–RNA interaction networks from large-scale CLIP-Seq data , 2013, Nucleic Acids Res..
[3] P. Pandolfi,et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology , 2010, Nature.
[4] Michael Y Tolstorukov,et al. The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites. , 2014, Molecular cell.
[5] A. Jemal,et al. Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.
[6] Yongjun Tan,et al. FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer. , 2015, Cancer letters.
[7] M. Gorospe,et al. Long Noncoding RNA MALAT1 Controls Cell Cycle Progression by Regulating the Expression of Oncogenic Transcription Factor B-MYB , 2013, PLoS genetics.
[8] Rajvir Dahiya,et al. Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205. , 2015, Cancer research.
[9] G. Goodall,et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.
[10] B. Blencowe,et al. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. , 2010, Molecular cell.
[11] J. Steitz,et al. Formation of triple-helical structures by the 3′-end sequences of MALAT1 and MENβ noncoding RNAs , 2012, Proceedings of the National Academy of Sciences.
[12] Z. Cai,et al. Hsa‐miR‐125b suppresses bladder cancer development by down‐regulating oncogene SIRT7 and oncogenic long non‐coding RNA MALAT1 , 2013, FEBS letters.
[13] K. Dahlman-Wright,et al. AP-1-mediated chromatin looping regulates ZEB2 transcription: new insights into TNFα-induced epithelial–mesenchymal transition in triple-negative breast cancer , 2015, Oncotarget.
[14] D. Cacchiarelli,et al. A Long Noncoding RNA Controls Muscle Differentiation by Functioning as a Competing Endogenous RNA , 2011, Cell.
[15] N. Seki,et al. Epithelial–mesenchymal transition-related microRNA-200s regulate molecular targets and pathways in renal cell carcinoma , 2013, Journal of Human Genetics.
[16] Michael Thomas,et al. MALAT-1, a novel noncoding RNA, and thymosin β4 predict metastasis and survival in early-stage non-small cell lung cancer , 2003, Oncogene.
[17] S. Diederichs,et al. MALAT1 — a paradigm for long noncoding RNA function in cancer , 2013, Journal of Molecular Medicine.
[18] J. Eberwine,et al. Immunoprecipitation of mRNA-protein complexes , 2006, Nature Protocols.
[19] Anders H. Lund,et al. microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus , 2013, Scientific Reports.
[20] K. Tang,et al. Prognostic value of meta-signature miRNAs in renal cell carcinoma: an integrated miRNA expression profiling analysis , 2015, Scientific Reports.
[21] Xing-Sui Lu,et al. miR-141 Is a Key Regulator of Renal Cell Carcinoma Proliferation and Metastasis by Controlling EphA2 Expression , 2014, Clinical Cancer Research.
[22] Qihong Huang,et al. Pseudogene PTENP1 Functions as a Competing Endogenous RNA to Suppress Clear-Cell Renal Cell Carcinoma Progression , 2014, Molecular Cancer Therapeutics.
[23] Meng Li,et al. Silencing of Long Noncoding RNA MALAT1 by miR-101 and miR-217 Inhibits Proliferation, Migration, and Invasion of Esophageal Squamous Cell Carcinoma Cells* , 2014, The Journal of Biological Chemistry.
[24] D. Spector,et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. , 2013, Cancer research.
[25] W Marston Linehan,et al. Genetic basis of kidney cancer: Role of genomics for the development of disease-based therapeutics , 2012, Genome research.
[26] Ping Wang,et al. Knockdown of long non-coding RNA HOTAIR inhibits malignant biological behaviors of human glioma cells via modulation of miR-326 , 2015, Oncotarget.
[27] F. Liu,et al. A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma. , 2014, Cancer cell.
[28] Fuqing Zeng,et al. Overexpression of SATB1 Is Associated with Biologic Behavior in Human Renal Cell Carcinoma , 2014, PloS one.
[29] Y. Nie,et al. Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression , 2014, Hepatology.
[30] H. Al-Ahmadie,et al. Recent developments in the pathology of renal tumors: morphology and molecular characteristics of select entities. , 2009, Archives of pathology & laboratory medicine.
[31] Junhua Zheng,et al. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma , 2015, Tumor Biology.
[32] David G. Knowles,et al. The GENCODE v7 catalog of human long noncoding RNAs: Analysis of their gene structure, evolution, and expression , 2012, Genome research.
[33] Lorenzo Farina,et al. Computational analysis identifies a sponge interaction network between long non-coding RNAs and messenger RNAs in human breast cancer , 2014, BMC Systems Biology.
[34] Phillip A Sharp,et al. A triple helix stabilizes the 3' ends of long noncoding RNAs that lack poly(A) tails. , 2012, Genes & development.
[35] Zhiquan Hu,et al. Epigenetic alterations of Krüppel-like factor 4 and its tumor suppressor function in renal cell carcinoma. , 2013, Carcinogenesis.
[36] Jun‐hang Luo,et al. Protein Expression of ZEB2 in Renal Cell Carcinoma and Its Prognostic Significance in Patient Survival , 2013, PloS one.